Liposome: classification, preparation, and applications
Липосомы: классификация, получение и применение
2013-02-22
SCID: 54.1/3c5nqbz7
Discuss with AI
drug delivery systemsliposomal drug formulationsliposomeslong-circulating liposomesphospholipid bilayers
Figures from the paper
Abstract (AI)
Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were first described in the mid-60s. Today, they are a very useful reproduction, reagent, and tool in various scientific disciplines, including mathematics and theoretical physics, biophysics, chemistry, colloid science, biochemistry, and biology. Since then, liposomes have made their way to the market. Among several talented new drug delivery systems, liposomes characterize an advanced technology to deliver active molecules to the site of action, and at present, several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles to 'second-generation liposomes', in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
Key Findings
1
Liposome technology enables targeted delivery of active molecules, and several liposomal drug formulations have reached clinical use.
2
Liposomes are phospholipid-bilayer vesicles with broad applications across physical, chemical, biological, and pharmaceutical sciences.
3
Second-generation liposomes achieve prolonged circulation by modifying vesicle lipid composition, size, and surface charge.
4
Surface engineering with glycolipids or sialic acid has produced modified liposomes with potentially tailored biological properties.
5
The review emphasizes scalable preparation techniques and evaluates their industrial applicability and regulatory limitations using FDA and EMEA documents.
Research Object
Liposomes (phospholipid bilayer vesicles used as drug delivery systems and research tools)
Research Subject
classification, scalable preparation techniques, surface and composition modifications, drug-delivery applications, and industrial and regulatory applicability
Publication Details
Publication Date
2013-02-22
Journal
Publisher
ISSN
Cited by
3638
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by9
Nano based drug delivery systems: recent developments and future prospects2018
Nanomaterials for cancer therapy: current progress and perspectives2021
Smart nanoparticles for cancer therapy2023
Photodynamic therapy: photosensitizers and nanostructures2021
Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications2017
Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment2022
Liposome and Their Applications in Cancer Therapy2016
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine2025
Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects2024